Perkins Capital Management’s WaferGen Bio-systems, Inc. WGBS Stock Holding History

Perkins Capital Management’s Portfolio WGBS Stock Details WGBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-135,300	Closed	-$433K	–	126
2016 Q1	$433K	Sell	135,300 -700	-0.5%	-$2.25K	0.54%	61
2015 Q4	$499K	Buy	+136,000	New	+$674K	0.54%	60
2014 Q4	–	Sell	-13,600	Closed	-$296K	–	143
2014 Q3	$296K	Buy	+13,600	New	+$303K	0.25%	97

Other funds holding WGBS

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MWM

Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FNYS

First New York Securities New York $53.7M AUM 57.01% 1-Year Est. Return

Perkins Capital Management's WGBS Position: Q2 2016 in Review

Perkins Capital Management sold out of WaferGen Bio-systems, Inc. (WGBS) in Q2 2016, closing a stake of 135,300 shares — an estimated $433K sold.

Perkins Capital Management first reported a position in WGBS in Q3 2014 and held it in 3 quarters. The position peaked at $499K in Q4 2015. 14 funds tracked by Wall St. Rank hold WGBS as of Q2 2016.

Perkins Capital Management reported no remaining WaferGen Bio-systems, Inc. position as of Q2 2016 after selling out during the quarter.
Perkins Capital Management sold 135,300 WaferGen Bio-systems, Inc. shares in Q2 2016, an estimated $433K.
Perkins Capital Management first reported a position in WaferGen Bio-systems, Inc. in Q3 2014 and held it in 3 quarters.
Perkins Capital Management's WaferGen Bio-systems, Inc. position peaked at $499K in Q4 2015.
14 funds tracked by Wall St. Rank held WaferGen Bio-systems, Inc. as of Q2 2016.

Based on Perkins Capital Management's 13F filing for Q2 2016, filed 20 Jul 2016.